{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:40:34Z","timestamp":1793972434988,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jsat.2010.07.009","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T07:04:51Z","timestamp":1283583891000},"page":"340-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["The SUMMIT Trial:"],"prefix":"10.1016","volume":"39","author":[{"given":"Hayley","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Maskrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Swift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Rumball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Wagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2010.07.009_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.285.1.39","article-title":"Deaths attributable to methadone vs. buprenorphine in France","volume":"285","author":"Auriacombe","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2010.07.009_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.07.009_bb0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","article-title":"Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention","volume":"104","author":"Burns","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.07.009_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0376-8716(99)00117-9","article-title":"Validation of the Christo Inventory for Substance-misuse Services (CISS): A simple outcome evaluation tool","volume":"59","author":"Christo","year":"2000","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.07.009_bb0025","series-title":"Drug misuse and dependence: UK Guidelines on Clinical Management","author":"DOH","year":"2007"},{"key":"10.1016\/j.jsat.2010.07.009_bb0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/hrt.2006.100180","article-title":"Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen","volume":"93","author":"Fanoe","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jsat.2010.07.009_bb0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.07.009_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.07.009_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pnpbp.2005.10.007","article-title":"Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study","volume":"30","author":"Gerra","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jsat.2010.07.009_bb0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: Impact of methadone treatment","volume":"82","author":"Gronbladh","year":"1990","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jsat.2010.07.009_bb0055","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2010.07.009_bb0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.07.009_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2006.10399832","article-title":"Predicting treatment retention with a brief \u201copinions about methadone\" scale","volume":"38","author":"Kayman","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2010.07.009_bb0070","first-page":"S29","article-title":"Implementing buprenorphine treatment in community settings in Australia: Experiences from the Buprenorphine Implementation Trial","volume":"13","author":"Lintzeris","year":"2004","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2010.07.009_bb0075","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(09)61420-3","article-title":"Effectiveness of community treatment for heroin and crack cocaine addiction in England: A prospective, in-treatment cohort study","volume":"374","author":"Marsden","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2010.07.009_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","article-title":"Buprenorphine versus methadone maintenance therapy: A randomised double-blind trial with 405 opioid-dependent patients","volume":"98","author":"Mattick","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.07.009_bb0085","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2010.07.009_bb0090","article-title":"Randomised clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","author":"Neri","year":"2001","journal-title":"Journal"},{"key":"10.1016\/j.jsat.2010.07.009_bb0095","unstructured":"NICE technology appraisal guidance 114, (2007) Methadone and buprenorphine for the management of opioid dependence. Available at: www.nice.org.uk\/TA114."},{"key":"10.1016\/j.jsat.2010.07.009_bb0100","author":"NTA"},{"key":"10.1016\/j.jsat.2010.07.009_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomised trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.07.009_bb0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14659890701639808","article-title":"Attitudes and knowledge of substance mis-users regarding buprenorphine and methadone maintenance therapy","volume":"13","author":"Pinto","year":"2008","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.jsat.2010.07.009_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/14659890701538810","article-title":"A pilot study for a randomized controlled and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients","volume":"13","author":"Pinto","year":"2008","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.jsat.2010.07.009_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2003.10.003","article-title":"Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: Results of a multi-center study of 73 patients","volume":"28","author":"Poirier","year":"2004","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jsat.2010.07.009_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02939579","article-title":"Co-abuse of opiates and benzodiazepines","volume":"168","author":"Rooney","year":"1999","journal-title":"Irish Journal of Medical Science"},{"key":"10.1016\/j.jsat.2010.07.009_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00005053-199801000-00006","article-title":"Prognostic factors in buprenorphine vs. methadone maintained persons","volume":"186","author":"Schottenfield","year":"1998","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1016\/j.jsat.2010.07.009_bb0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"American Journal on Addiction"},{"key":"10.1016\/j.jsat.2010.07.009_bb0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"International Journal of Neuropsychopharmacol"},{"key":"10.1016\/j.jsat.2010.07.009_bb0145","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.151.7.1025","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence","volume":"151","author":"Strain","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.07.009_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jsat.2006.03.007","article-title":"Multimodal drug addiction treatment: A field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients","volume":"31","author":"Vigezzi","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.07.009_bb0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:35:04Z","timestamp":1760038504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547210001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0740547210001625"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2010.07.009","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SUMMIT Trial:","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2010.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}